Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EBOS Group Limited ( (AU:EBO) ) just unveiled an update.
EBOS Group Limited has declared an ordinary dividend of NZD 0.59514706 per fully paid share for the six-month period ended 31 December 2025. The distribution timetable sets 5 March 2026 as the ex-dividend date, 6 March 2026 as the record date and 27 March 2026 as the payment date, with a dividend reinvestment plan election cutoff on 9 March 2026.
The announcement underscores EBOS’s ongoing commitment to returning capital to shareholders through regular dividends, signalling continued cash generation from its core operations. The confirmed schedule provides clarity for investors seeking income and may support the stock’s appeal to yield-focused holders in the healthcare distribution sector.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$26.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is a healthcare and pharmaceutical distributor listed on the ASX under the code EBO. The company issues ordinary fully paid shares and operates on a semi-annual reporting and distribution cycle, reflecting its role as a mature, dividend-paying participant in the Australasian healthcare supply chain.
Average Trading Volume: 136,505
Technical Sentiment Signal: Sell
Current Market Cap: A$4.29B
Learn more about EBO stock on TipRanks’ Stock Analysis page.